http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
AttackIQ Named to 2025 MES Midmarket 100 List for Democratizing Security Testing for Midsize Enterprises
-
Merck launches phase 3 trials for monthly HIV prevention pill
-
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
-
Gilead presents data on twice-yearly HIV prevention drug at IAS 2025
-
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
-
Wayne-Sanderson Farms Named the "Official Chicken of the Southeastern Conference (SEC)"
-
Little Pepe Crosses $6.3M as Stage 5 Presale Nears Sellout
-
Leveraging Digital Advancements and Big Data in Food Marketing and Policy
-
Global Consultancy Baringa Expands its U.S. Presence with Acquisition of Altruas Team
-
KFC® Begins its Comeback Era, Issues Come Back Call to Fried Chicken Fans with Free Bucket On Us* Offer
-
MacKay Municipal Managers Provides a Mid-Year Update to Top Five Municipal Market Insights For 2025
-
Fobi AI Announces CFO Transition, Taps Long-Tenured Board Member Jeffrey Hyman as CFO
-
Check Point Software Technologies Releases its 2024 Environment, Social, Governance (ESG) Report
-
General Enterprise Ventures Appoints Andrew Hotsko as Chief Operating Officer
-
10th Annual TennoCon Fan Event Celebrating the 85+ Million Player Game Warframe to Run July 18-19 in London, Ontario
-
ESGold Unlocks District-Scale Discovery Potential at Montauban with Geological Structures Extending to 1,200m
-
Why Immediate Medical Treatment After a Florida Crash Could Save Your Health and Your Case, According to Dennis Hernandez Injury Attorneys
-
Waffle Tacos & Daily Deals: Cold Stone Creamery® Makes Ice Cream Month Even Sweeter
-
Ascot U.S. Implements Guidewire to Transform Claims IT Operations
-
Bug Bite Thing Now Offering Tick Testing
-
Mark Groenheide's Leadership Spurs Parametric Insurance Surge Through Rapid Claims Success
-
IMAX earns $30.4 million globally from Superman opening weekend
-
IMAX® Soars To $30.4 Million Global Opening for “Superman”
-
Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic
-
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala
-
Battery Mineral Resources Announces the Filing of Q1 2025 Financials and the Appointment of Keith Spano to the Board of Directors and Head of the Audit Committee
-
Stratasys launches P3 Silicone 25A material with Shin-Etsu partnership
-
Stratasys and Shin-Etsu Launch P3™ Silicone 25A for Industrial-Grade Additive Manufacturing Applications
-
Daré Bioscience reports interim Phase 3 results for hormone-free contraceptive
-
LMP Capital and Income Fund Inc. Announces Preliminary Results of Transferable Rights Offering
-
Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive
-
American Diversified Holdings Corporation (ADHC) Provides Udpate on Arete Bioscience GlucoGuard Design Project
-
Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025
-
Soluna Holdings reports revenue growth of 80% to $38 million in 2024
-
DeFi Technologies bitcoin holdings hit record $25.6 million valuation
-
Zimmer Biomet to acquire Monogram Technologies for $177 million
-
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
-
DeFi Technologies Reports All-Time High in Bitcoin Assets Under Management and Treasury Holdings
-
Soluna Holdings’ CEO John Belizaire Shares Vision for Scalable Renewable Computing in 2025 Shareholder Letter
-
Digital Asset Technologies Inc. Poised for Growth Amidst Surging Digital Asset Market and Key Ecosystem Advancements
-
Bio-Techne technology used in FDA-approved gene therapy ZEVASKYN
-
New Break Begins Maiden Drilling Program at the Moray Gold Project
-
Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy
-
BTCS reaches $96.3 million in crypto and cash holdings
-
BTCS Reaches $96.3 Million in Combined Crypto and Cash Market Value, Including 29,122 ETH Holdings
-
Karmanos Cancer Institute Recognizes Sarcoma Awareness Month
-
Waters to merge with BD's biosciences unit in $17.5 billion deal
-
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
-
Netrality Data Centers Announces New High-Density Data Hall at its Indy Telcom Center
-
Expro Secures Contract With Woodside Energy for Trion Deepwater Project
